Starpharma Holdings (Starpharma Holdings) Institutional Ownership : 18.58% (As of Jun. 08, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Starpharma Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Starpharma Holdings's institutional ownership is 18.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Starpharma Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Starpharma Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.

Starpharma Holdings Institutional Ownership Historical Data

The historical data trend for Starpharma Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Institutional Ownership Chart

Starpharma Holdings Historical Data

The historical data trend for Starpharma Holdings can be seen below:

	2023-07-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	33.14	28.22	23.30	19.47	18.78	19.09	18.72	18.60	18.58	18.58

Starpharma Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

SPHRY:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.